MA23254A1 - Procede de preparation de nouveaux composes - Google Patents

Procede de preparation de nouveaux composes

Info

Publication number
MA23254A1
MA23254A1 MA23564A MA23564A MA23254A1 MA 23254 A1 MA23254 A1 MA 23254A1 MA 23564 A MA23564 A MA 23564A MA 23564 A MA23564 A MA 23564A MA 23254 A1 MA23254 A1 MA 23254A1
Authority
MA
Morocco
Prior art keywords
preparation
new compounds
compounds
new
Prior art date
Application number
MA23564A
Other languages
English (en)
Inventor
Thomson Forbes Ian
Ham Peter
Elgin Jones Graham
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA23254A1 publication Critical patent/MA23254A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Eyeglasses (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA23564A 1993-07-06 1994-07-04 Procede de preparation de nouveaux composes MA23254A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939313913A GB9313913D0 (en) 1993-07-06 1993-07-06 Novel compounds

Publications (1)

Publication Number Publication Date
MA23254A1 true MA23254A1 (fr) 1995-04-01

Family

ID=10738344

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23564A MA23254A1 (fr) 1993-07-06 1994-07-04 Procede de preparation de nouveaux composes

Country Status (15)

Country Link
US (1) US5834494A (fr)
EP (1) EP0707581B1 (fr)
JP (1) JPH08512299A (fr)
CN (1) CN1129937A (fr)
AP (1) AP463A (fr)
AT (1) ATE149163T1 (fr)
AU (1) AU7228394A (fr)
CA (1) CA2166624A1 (fr)
DE (1) DE69401823T2 (fr)
GB (1) GB9313913D0 (fr)
IL (1) IL110204A0 (fr)
MA (1) MA23254A1 (fr)
TW (1) TW297023B (fr)
WO (1) WO1995001976A1 (fr)
ZA (1) ZA944807B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618824A (en) * 1994-03-09 1997-04-08 Merrell Pharmaceuticals Inc. Treatment of obsessive-compulsive disorders with 5-HT2 antagonists
GB9414139D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Novel compounds
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
BR9607016A (pt) * 1995-02-02 1997-10-28 Smithkline Beecham Plc Derivados de indol como antagonísta de receptor 5-ht
JPH10513443A (ja) * 1995-02-02 1998-12-22 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 5HT▲下2c▼レセプターアンタゴニスト活性を有する複素環化合物
GB9517559D0 (en) * 1995-08-26 1995-10-25 Smithkline Beecham Plc Novel compounds
CA2253941A1 (fr) * 1996-05-16 1997-11-20 Sumanas Rakhit Derives de la thiophenetryptamine et de la furanetryptamine
GB9612883D0 (en) 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
GB9612885D0 (en) 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
US6362009B1 (en) 1997-11-21 2002-03-26 Merck & Co., Inc. Solid phase synthesis of heterocycles
FR2778662B1 (fr) * 1998-05-12 2000-06-16 Adir Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1122252A4 (fr) * 1998-10-16 2002-06-26 Takeda Chemical Industries Ltd Composes azotes hererocycliques condenses; procede de fabrication et agents les renfermant
US6453357B1 (en) 1999-01-07 2002-09-17 Cisco Technology, Inc. Method and system for processing fragments and their out-of-order delivery during address translation
ES2252004T3 (es) * 1999-05-21 2006-05-16 Biovitrum Ab Nuevos compuestos, su uso y preparacion.
US6465467B1 (en) 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
UA77650C2 (en) 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
FR2810979B1 (fr) * 2000-06-29 2002-08-23 Adir Nouveaux derives de diphenyluree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB0019950D0 (en) * 2000-08-12 2000-09-27 Smithkline Beecham Plc Compounds
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
EP1278085B1 (fr) * 2001-07-09 2003-05-21 Alcatel Connecteur pour fibres optiques
US6861440B2 (en) 2001-10-26 2005-03-01 Hoffmann-La Roche Inc. DPP IV inhibitors
FR2837823B1 (fr) * 2002-03-27 2005-04-08 Servier Lab Nouveaux derives d'indoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BR0311970A (pt) 2002-06-19 2005-03-29 Biovitrum Ab Novos compostos, seu uso e preparação
HRP20110018T1 (hr) 2003-06-20 2011-02-28 F. Hoffmann - La Roche Ag Derivati pirido(2,1-a)-izokinolina kao inhibitori dpp-iv
AU2004251829B2 (en) 2003-06-20 2009-12-17 F. Hoffmann-La Roche Ag Hexahydropyridoisoqinolines as DPP-IV inhibitors
US8183296B2 (en) * 2005-09-13 2012-05-22 Bayer Cropscience Ag Pesticide phenyloxy substituted phenylamidine derivatives
US9052304B2 (en) 2009-03-13 2015-06-09 Terrasep, Llc Methods and apparatus for centrifugal liquid chromatography
CN106278987A (zh) * 2016-08-16 2017-01-04 都创(上海)医药科技有限公司 吲哚啉类化合物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428881A (en) * 1977-12-23 1984-01-31 Gulf Oil Corporation Control of unwanted vegetation with N-carbamylindolines
JPH06500551A (ja) * 1990-09-13 1994-01-20 ビーチャム・グループ・パブリック・リミテッド・カンパニー 5ht受容体アンタゴニストとしてのインドールウレア
AU4704693A (en) * 1992-08-20 1994-03-15 Smithkline Beecham Plc Condensed indole derivatives as 5HT-2C and 5HT-2B antagonists

Also Published As

Publication number Publication date
AP9400653A0 (en) 1994-07-31
IL110204A0 (en) 1995-01-24
TW297023B (fr) 1997-02-01
JPH08512299A (ja) 1996-12-24
CN1129937A (zh) 1996-08-28
DE69401823T2 (de) 1997-08-28
AU7228394A (en) 1995-02-06
EP0707581B1 (fr) 1997-02-26
ZA944807B (en) 1996-01-04
AP463A (en) 1996-02-19
EP0707581A1 (fr) 1996-04-24
GB9313913D0 (en) 1993-08-18
CA2166624A1 (fr) 1995-01-19
US5834494A (en) 1998-11-10
ATE149163T1 (de) 1997-03-15
WO1995001976A1 (fr) 1995-01-19
DE69401823D1 (de) 1997-04-03

Similar Documents

Publication Publication Date Title
MA23254A1 (fr) Procede de preparation de nouveaux composes
MA22923A1 (fr) Procede de preparation de nouveaux composes .
MA23270A1 (fr) Procede pour la preparation de nouveaux composes.
MA22922A1 (fr) Procede pour la preparation de nouveaux composes .
MA23792A1 (fr) Procede pour la preparation de nouveaux composes
MA24011A1 (fr) Procede pour la preparation de nouveaux composes
MA22970A1 (fr) Procede de praparation de nouveaux composes.
MA23802A1 (fr) Procede pour la preparation de nouveaux composes
MA24426A1 (fr) Procede pour la preparation de nouveaux composes
MA24427A1 (fr) Procede pour la preparation de nouveaux composes
MA22955A1 (fr) Procede pour la preparation de nouveaux composes .
MA23309A1 (fr) Procede de preparation de nouveaux composes.
FR2764603B1 (fr) Procede de preparation de composes de type ceramides
EP0833814A4 (fr) Procede de preparation d'hydroxyalkylamides
MA22860A1 (fr) Procede pour la preparation de nouveaux composes.
MA24355A1 (fr) Procede de preparation de nouveaux composes
MA23041A1 (fr) Procede de preparation de composes benzopyraniques substitues.
MA23036A1 (fr) Procede pour la preparation de composes.
ITMI931680A1 (it) Procedimento per la preparazione di alcansolfonammidi
FR2768725B1 (fr) Procede de preparation du 2-chloroprop-1-ene
FR2626883B1 (fr) Procede de preparation de n-phosphonomethyl-imino-diacetique
EP0823904A4 (fr) Procede de preparation de spiroindolines
MA24245A1 (fr) Procede pour la preparation de nouveaux composes sulfonylures
NO940171L (no) Fremgangsmåte for kontinuerlig fremstilling av dimetoksyetanal
MA22927A1 (fr) Procede pour la preparation de nouveaux composes.